GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R (1) (a) I give details of changes in the interests of Persons Discharging Managerial Responsibilities ("PDMR's"), in the Ordinary Shares of GlaxoSmithKline plc (the "Company") as follows:
PDMR |
Transaction
|
C Thomas |
The sale of 17,000 Ordinary Shares on 30 March 2016 at a price of £14.08 per share.
|
P Vallance
|
The exercise of a nil priced option over 33,406 Ordinary Shares on 30 March 2016, granted on 28 February 2013, which vested on 28 February 2016 under the GlaxoSmithKline Deferred Annual Bonus Plan.
The sale of 24,251 Ordinary Shares on 30 March 2016 at a price of £14.12.
The sale of 9,155 Ordinary Shares on 30 March 2016 at a price of £14.11.
|
The Company and the above-mentioned PDMR's were advised of these transactions on 30 March 2016.
V A Whyte
Company Secretary
30 March 2016